Biocompatible nanomaterials for targeted and controlled delivery of biomacromolecules
By: Deepak N. Kapoor and Sanju Dhawan
Contributors: Dhawan, Sanju, author
Series: Biomedical & nanomedical technologies; Biomedical & nanomedical technologies
Publisher: ASME Press/Momentum Press
Published: 2013
Place of publication: New York,NY
Language: eng
Number of pages: 47
ISBN-13: 9780791860113; 9781606506028
Subjects: Macromolecules; Nanostructured materials; Drug delivery systems; Nanomedicine; Nanostructures; Drug Delivery Systems
Notes: Includes bibliographical references (pages 38-47).
Table of contents: title: 1. Nanomaterials: a brief introduction; title: 2. Tissue and blood-material interactions; title: 2.1 Tissue response; title: 2.2 Blood response; title: 2.3 Cellular response; title: 3. Biocompatibility; title: 4. Biodegradation; title: 5. Biocompatible and biodegradable nanomaterials; title: 5.1 Organic nanomaterials; title: 5.1.1 Natural and modified natural nanomaterials; title: 5.1.2 Synthetic polymeric nanomaterials; title: 5.2 Stealth nanomaterials; title: 5.3 Inorganic nanomaterials; title: 5.3.1 Carbon nanotubes (CNTs); title: 5.3.2 Quantum dots (QDs); title: 5.3.3 End-capped mesoporous silica nanoparticles; title: 5.4 Metal nanoparticles; title: 5.4.1 Gold nanoparticles (Au-Nps); title: 5.4.2 Silver nanoparticles; title: 5.5 Magnetic nanoparticles; title: 5.6 Nanocomposites, nanofibres and nanowires; title: 5.7 Hybrid nanomaterials; title: 5.8 Virus-like nanocarriers; title: 5.9 Multifunctional nanoparticles; title: 6. Biomacromolecules; title: 6.1 Cell penetrating peptides in biomacromolecular delivery; title: 6.2 Targeted biomacromolecular delivery.; title: 7. Challenges in biomacromolecular delivery; title: 8. Preparation techniques of biocompatible nanostructures; title: 8.1 Top-down techniques; title: 8.1.1 Dispersion of preformed polymers; title: 8.1.2 Polymerization methods; title: 8.1.3 Ionic gelation method for hydrophilic polymers; title: 8.1.4 Hybrid assemblies; title: 8.2 Bottom-up techniques; title: 8.3 Scalable methods; title: 9. Characterization and evaluation; title: 9.1 Drug-polymer compatibility; title: 9.2 Particle size and shape; title: 9.3 Zeta potential; title: 9.4 Drug release evaluation; title: 9.5 Conformational stability; title: 9.6 Biocompatibility studies; title: 9.7 Pre-clinical evaluation; title: 10. Regulatory perspectives; title: 11. Industrial viability; title: 12. Conclusions.